Why gsk uk

The subsequent websites and web pages are intended for non-UK audiences. We are one of the largest global healthcare companies researching, developing and supplying innovative medicines, vaccines and healthcare products with our global headquarters in the UK. We focus on what matters most to our people, this means managers helping employees to be themselves, feel good and keep growing, in ways that work for them.

We also support our global and local communities. We routinely monitor the safety of all our medicines and all adverse events should be reported to us and the Medicines and Healthcare products Regulatory Agency via their yellow card scheme. If you would like to report an adverse event, please use our Report Adverse Events form. Email: Customer. As a healthcare company we regularly work with HCPs. From collaborating on clinical trials to providing high quality, balanced information about our medicines and vaccines, in all of our interactions we aim to be transparent about our work, operate with integrity, and always put the interests of patients first.

You can find more information on our disclosure of payments here. Despite having some of the best people and research facilities, experience has shown us that we can achieve even more through strong partnerships. These can be with the NHS, other companies, non-profit organisations and the academic world. By working together we aim to improve the management of different conditions, introduce greater efficiency and to achieve our mission to help people to do more, feel better, live longer.

The projects outlined below were undertaken over the last five years and, over this period, codes, regulations and laws governing the areas covered by the studies may have changed. When reading the documents please be assured that all projects followed the particular standards in force at the time even though these may have subsequently changed.

All of the featured case studies are intended to give an overview of the individual project including its background, the potential benefits for the patient, the NHS, GSK and any other stakeholders. In all of our interactions we aim to be transparent about our work, operate with integrity, and always put the interests of patients first.

We focus our financial resource on programmes that have the greatest potential to enable people to do more, feel better, live longer. That move is designed to let it focus on developing new drugs and vaccines. GSK boss faces crunch meeting with investors. Drugs firm to close two UK antibiotics plants.

Drug firms make global vaccine supply deal. Image source, GSK. GSK plans to build the new centre at its site at Stevenage in Hertfordshire. You are currently visiting our global website. United Kingdom. See Disclosure UK.